From: Comparisons of gene coexpression network modules in breast cancer and ovarian cancer
No. | KEGG ID | Description | p-value |
---|---|---|---|
5 | hsa03010 | Ribosome | 1.02E-43 |
14 | hsa04668 | TNF signaling pathway | 3.80E-09 |
 | hsa04657 | IL-17 signaling pathway | 1.97E-06 |
 | hsa05323 | Rheumatoid arthritis | 4.57E-05 |
 | hsa04380 | Osteoclast differentiation | 1.96E-04 |
 | hsa04010 | MAPK signaling pathway | 3.00E-04 |
23 | hsa05217 | Basal cell carcinoma | 2.59E-05 |
 | hsa05200 | Pathways in cancer | 9.26E-05 |
33 | hsa04610 | Complement and coagulation cascades | 2.68E-06 |
36 | hsa00480 | Glutathione metabolism | 1.12E-10 |
 | hsa00982 | Drug metabolism-cytochrome P450 | 1.43E-10 |
 | hsa01524 | Platinum drug resistance | 1.43E-10 |
 | hsa00980 | Metabolism of xenobiotics by cytochrome P450 | 1.43E-10 |
 | hsa05204 | Chemical carcinogenesis | 1.93E-10 |
 | hsa05418 | Fluid shear stress and atherosclerosis | 2.37E-09 |